1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

15 Mar 2024
Admin
News Article

USV Starts New Manufacturing Plant in Baddi

USV opens new manufacturing plant in Baddi to strengthen cardiology segment

Overview

USV, an Indian multinational healthcare company, announced the opening of a dedicated new manufacturing plant in Baddi, The new dedicated facility will improve access to high quality and affordable Ecosprin AV and further strengthen its leadership in the cardiology segment. With this new facility, the product will now be available in a more patient friendly pack.

Increasing Risk

There are an increasing number of cases of cardiac events in our country even for younger individuals. Aspirin and atorvastatin play a vital role in heart health to protect patients from cardiac events.

Plant Inauguration

The plant was inaugurated by Debabrata Bhadury, director, USV in the presence of USV chairperson Leena Gandhi Tewari and managing director Prashant Tewari.

Leaders on Inauguration

“This modern facility is of strategic importance to serve Indians to keep their heart healthy by offering a lifesaving quality brand at an affordable price”, said Leena Gandhi Tewari at the plant inauguration.
Prashant Tewari, managing director said “This new unit at Baddi will contribute further to our responsibility of saving lives through offering quality medicines.”

The New Facility

The plant uses high-tech machinery and advanced technology in manufacturing and automated process checks to assure product quality and efficacy.
This meets the long term endeavour of contributing effectively to the well-being of patients with heart ailments by enhancing patient outcomes.
The plant has many green initiatives like renewable energy usage, rainwater harvesting, and tree plantation already incorporated, right from inception.

Director’s Word on the Plant

M M Venkatachalam, director USV said “The facility is very impressive and upgraded in terms of technology used, automation, QC, testing and sustainability practice. In the recent past USV has made great strides in new facilities, technologies, efficiencies, and capacities.”

About USV

Established in 1961, USV Private Limited is one of the leading Indian multinational healthcare companies with a presence in 65+ countries, with its products. In India, it is recognized for its leadership in the oral anti-diabetic and cardiology markets where it ranks #1 by prescriptions.